Forma Therapeutics Holdings (FMTX) Misses Q2 EPS by 11c
Tweet
Share
E-mailGet Alerts FMTX Hot Sheet
Join SI Premium – FREE
Forma Therapeutics Holdings (NASDAQ: FMTX) reported Q2 EPS of ($1.10), $0.11 worse than the analyst estimate of ($0.99). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .
For earnings history and earnings-related data on Forma Therapeutics Holdings (FMTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- L3Harris CEO steps down amid conduct review, shares drop
- Nuvve Holdin (NVVE) Misses Q2 EPS by 1445c
- InspireMD (NSPR) Tops Q2 EPS by 1c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
